London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
Oxford Nanopore Technologies
David Thomas
- Job title
- Institution
- University of New South Wales, Australia
- Biography
David Thomas is the inaugural Director of the Centre for Molecular Oncology at the University of New South Wales and Chief Strategy and Science Officer at Omico. As a clinician-scientist, his focus is on the application of genomic technologies to the understanding and management of cancer, particularly sarcoma. He established the not-for-profit company, Australian Genomic Cancer Medicine Centre, trading as Omico, to lead a national precision medicine program for patients with rare and early onset cancers. He has over 200 research publications, including lead or senior author papers in Science, Cancer Cell, Journal of Clinical Investigation, and The Lancet Oncology.
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
